Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Arber

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Blood|February 8, 2024
Two to tango: engineered T cells against AMLCaroline Arber
Frontiers in Immunology|May 16, 2022
Rapid Generation of TCR and CD8αβ Transgenic Virus Specific T Cells for Immunotherapy of LeukemiaGagan Bajwa, Caroline Arber
Cells|June 24, 2020
Engineering Strategies to Enhance TCR-Based Adoptive T Cell TherapyJan A Rath, Caroline Arber
Current Opinion in Biotechnology|July 15, 2017
Reprogramming cellular functions with engineered membrane proteinsCaroline Arber, Melvin Young, Patrick Barth
Frontiers in Immunology|December 2, 2020
Off-the-Shelf Allogeneic T Cell Therapies for Cancer: Opportunities and Challenges Using Naturally Occurring "Universal" Donor T CellsCynthia Perez, Isabelle Gruber, Caroline Arber
Seminars in Hematology|November 13, 2013
Mouse models in bone marrow transplantation and adoptive cellular therapyCaroline Arber, Malcolm K Brenner, Pavan Reddy
Nature Reviews. Drug Discovery|February 3, 2025
Novel strategies to manage CAR-T cell toxicityArthur Mulvey, Lionel Trueb, George Coukos, et al.
Journal of Clinical Pathology|April 27, 2010
GATA1 mutations are not a hallmark of acute myeloid leukaemia with t(8;21)Sylvia Hoeller, Michel P Bihl, Caroline Arber, et al.
Journal for Immunotherapy of Cancer|November 5, 2020
Transgenic CD8αβ co-receptor rescues endogenous TCR function in TCR-transgenic virus-specific T cellsGagan Bajwa, Inès Lanz, Mara Cardenas, et al.
Drug Safety|January 17, 2019
Safety and Tolerability of Adoptive Cell Therapy in CancerBenita Wolf, Stefan Zimmermann, Caroline Arber, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Blood|February 8, 2024
Two to tango: engineered T cells against AMLCaroline Arber
Frontiers in Immunology|May 16, 2022
Rapid Generation of TCR and CD8αβ Transgenic Virus Specific T Cells for Immunotherapy of LeukemiaGagan Bajwa, Caroline Arber
Cells|June 24, 2020
Engineering Strategies to Enhance TCR-Based Adoptive T Cell TherapyJan A Rath, Caroline Arber
Current Opinion in Biotechnology|July 15, 2017
Reprogramming cellular functions with engineered membrane proteinsCaroline Arber, Melvin Young, Patrick Barth
Frontiers in Immunology|December 2, 2020
Off-the-Shelf Allogeneic T Cell Therapies for Cancer: Opportunities and Challenges Using Naturally Occurring "Universal" Donor T CellsCynthia Perez, Isabelle Gruber, Caroline Arber
Seminars in Hematology|November 13, 2013
Mouse models in bone marrow transplantation and adoptive cellular therapyCaroline Arber, Malcolm K Brenner, Pavan Reddy
Nature Reviews. Drug Discovery|February 3, 2025
Novel strategies to manage CAR-T cell toxicityArthur Mulvey, Lionel Trueb, George Coukos, et al.
Journal of Clinical Pathology|April 27, 2010
GATA1 mutations are not a hallmark of acute myeloid leukaemia with t(8;21)Sylvia Hoeller, Michel P Bihl, Caroline Arber, et al.
Journal for Immunotherapy of Cancer|November 5, 2020
Transgenic CD8αβ co-receptor rescues endogenous TCR function in TCR-transgenic virus-specific T cellsGagan Bajwa, Inès Lanz, Mara Cardenas, et al.
Drug Safety|January 17, 2019
Safety and Tolerability of Adoptive Cell Therapy in CancerBenita Wolf, Stefan Zimmermann, Caroline Arber, et al.
Pageof 5